People
Nisha Nanda
Nisha Nanda leads Lilly Catalyze360 as group vice president, expanding engagement with emerging biotechnology companies. She previously led development and R&D operations at Loxo Oncology and joined Lilly through its 2019 acquisition. Her earlier drug-development work includes Onyx, ChemGenex and Portola; she trained in biochemistry and molecular genetics in Australia.
Roles
Eli Lilly and Company
CurrentGroup Vice President, Head of Lilly Catalyze360